In this issue:
Concomitant chemotherapy or cetuximab alongside radiotherapy for HNSCC
Larynx cancer trends in the USA
A brief video tele-CBT framework (BRIGHT) for head & neck cancer survivors with body image distress
Pembrolizumab vs. pembrolizumab-chemotherapy vs. cetuximab-chemotherapy in HNSCC
TMC + low-dose nivolumab in HNSCC
Outcomes following salvage surgery after locoregional failure for HPV+ OPSCC
MEDI0457 HPV vaccine + durvalumab in recurrent/metastatic HPV-16/18-associated HNSCC
Survival outcomes in adolescent/young adults vs. older adults with tongue squamous cell carcinoma
Prognostic ability of EBVCL+TVRR in predicting survival for locally advanced nasopharyngeal carcinoma after IC
TNM stage + Epstein-Barr virus DNA load after IC to guide chemotherapy intensity in locally advanced nasopharyngeal carcinoma
Please login below to download this issue (PDF)